Objective : To report the on-going status of randomized prospective study compared functional outcomes and complications over 12 months in BPH treated with ThuLEP or bipolar TURP.
Methods : We evaluated functional outcomes in 110 patients with BPH, in a randomized prospective study using IPSS, IPSS QOL, OABSS, uroflowmetry, and IIEF-5. Scores were taken before treatment and at 1, 3, 6, 9 and 12 months afterward.
Results : Both groups had significantly improved IPSS, IPSS QOL, OABSS, and uroflowmetry compared with pre-operative values. The ThuLEP group had lower median decrease in Hb (0.2 g/dL vs. 0.8 g/dL, P=0.032) and shorter median catheterization (1 day vs. 2 days, P=0.048) than the bipolar TURP group. In the ThuLEP group, erectile function was significantly impaired at 1 month post-treatment compared with pre-treatment, but improved to baseline at 3 months.
Conclusions : ThuLEP is superior to bipolar TURP in hemostasis, catheterization time, and preservation of erectile function in the progress report.
View full abstract